DPP4 and COVID-19: A large interface has been predicted in the docking of DPP-4/SARS-CoV-2 spike protein [49], and it seems that the S1 domain of COVID-19 spike glycoprotein may interact with the human DPP4, a key immunoregulatory factor for hijacking and virulence [50].